Kenanga Investment Bank Bhd operates in the Security brokers and dealers sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kenanga Investment Bank Bhd with three other
financial institutions in Asia:
Emperor Capital Group Ltd
of Hong Kong
sales of 1.24 billion Hong Kong Dollars [US$158.80 million]
of which 67%
China Medical & HealthCare Group Ltd
of Hong Kong
(1.28 billion Hong Kong Dollars [US$164.34 million]
of which 61%
was Healthcare), and
Masterlink Securities Corp
based in Taiwan
(4.88 billion Taiwanese Dollars [US$158.15 million]
of which 49%
Kenanga Investment Bank Bhd reported sales of 666.77 million Malaysian Ringgits (US$159.29 million)
December of 2017.
increase of 14.6%
versus 2016, when the company's sales were 582.04 million Malaysian Ringgits.
Sales of Investment Management saw an increase
that was more than double the company's growth rate: sales were up
91.2% in 2017, from
43.21 million Malaysian Ringgits to 82.61 million Malaysian Ringgits.
Kenanga Investment Bank Bhd also saw significant increases in sales in
Stockbroking (up 24.9% to 312.99 million Malaysian Ringgits)
Not all segments of Kenanga Investment Bank Bhd experienced an increase in sales in 2017:
sales of Money Lending and Financing fell 43.4% to 7.76 million Malaysian Ringgits.
(However, this segment's sales were only a very small portion of the company's overall sales).
Kenanga Investment Bank Bhd also experienced decreases in sales in
Support and Others (down 24.4% to 14.84 million Malaysian Ringgits)
Futures (down 33.4% to 13.05 million Malaysian Ringgits)